ARMS Medical secures industry recognition as its VNEW mesh-free dermal allograft is named the Top Pelvic Floor Surgery Technology of 2026 by MedTech Outlook.
The company's product VNEW received a technology award, which is a positive recognition but not a major financial event.
ARMS Medical announced that its VNEW dermal allograft has been recognized as the Top Pelvic Floor Surgery Technology of 2026 by MedTech Outlook. The mesh-free product is designed specifically for female pelvic floor reconstruction, marking a significant industry milestone for the company's proprietary technology.
The award from MedTech Outlook validates the clinical design of ARMS Medical's mesh-free dermal allograft in the pelvic floor reconstruction market.